Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Uterine Neoplasms 1 Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Paclitaxel 10 Surveys and Questionnaires 6 Cisplatin 6 Carboplatin 5 pembrolizumab 4 Brachytherapy 4 Hyperthermic Intraperitoneal Chemotherapy 3 Gemcitabine 3 Doxorubicin 3 Docetaxel 3 olaparib 2 niraparib 2 durvalumab 2 Topotecan 2 Taxes 2 Standard of Care 2 Sentinel Lymph Node Biopsy 2 Saline Solution 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Music Therapy 2 Mitomycin 2 Letrozole 2 Imagery, Psychotherapy 2 Hysterectomy 2 Exercise 2 Everolimus 2 Blood Specimen Collection 2 ulipristal acetate 1 temsirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Uterine Neoplasms × 16-fluoroestradiol × Clear all

NCT05916196 2025-05-08

[18F]FES PET/.CT in Uterine Cancer

Abramson Cancer Center at Penn Medicine

Phase 2 Recruiting

Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡